Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USP Model Is “Starting Point”; CMS Formulary Standards Will Be True Test

Executive Summary

U.S. Pharmacopeia's model drug classification system is only a "starting point" in developing a Medicare formulary that will pass muster with the Centers for Medicare & Medicaid Services

You may also be interested in...



Medicare Rx Dual-Eligibles Will Influence Formulary Design, Insurer Says

The large number of dual-eligibles who will be moved from Medicaid to Medicare drug coverage in 2006 should be taken into account when plans design Part D Rx formularies, Ovations Chief Pharmacy Officer Thomas Paul said

Medicare Rx Dual-Eligibles Will Influence Formulary Design, Insurer Says

The large number of dual-eligibles who will be moved from Medicaid to Medicare drug coverage in 2006 should be taken into account when plans design Part D Rx formularies, Ovations Chief Pharmacy Officer Thomas Paul said

Part D Plans Need Mandatory Generic Programs Without Carve-Outs – GPhA

The Centers for Medicare & Medicaid Services should require Medicare prescription drug plans to implement mandatory generic drug substitution programs that do not contain "carve-outs" for certain classes of brand drugs, the Generic Pharmaceutical Association said

Related Content

Topics

UsernamePublicRestriction

Register

LL1134025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel